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Abstract The fraudulent addition of hazelnut oil to more
expensive olive oil not only causes economical loss but
may also result in problems for allergic individuals as they
may inadvertently be exposed to potentially allergenic
hazelnut proteins. To improve consumer safety, a rapid
and sensitive direct biosensor immunoassay, based on a
highly specific monoclonal antibody, was developed to
detect the presence of hazelnut proteins in olive oils. The
sample preparation was easy (extraction with buffer); the
assay time was fast (4.5 min only) and the limit of detection
was low (0.08 μg/g of hazelnut proteins in olive oil).
Recoveries obtained with an olive oil mixed with different
amounts of a hazelnut protein containing hazelnut oil varied
between 93% and 109%.
Keywords Biosensor . Immunoassay .Monoclonal
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Introduction
Undeclared traces of allergenic substances in food may
cause problems for allergic individuals as they are
inadvertently exposed to the offending food. In particular,
traces of peanut and hazelnut are a risk as they can elicit
severe reactions [1–3]. Traces of hazelnut proteins might
unexpectedly be present in olive oils as, for unethical olive
oil producers and importers, it may be economically
attractive to adulterate extra virgin olive oils with less-
expensive hazelnut oil. Within the European Union, this
adulteration causes an estimated loss of four million euros
per year [4]. Apart from economical loss, this adulteration
may also cause problems for hazelnut-allergic individuals
as Teuber et al. [5] showed that sera from allergic patients
react with extract of hazelnut oil. It is now accepted that the
allergenicity of edible oils is a function of the residual
protein remaining after pressing and, if applicable, refining
and other processing. Crude oils, having the highest protein
content, provoke the majority of reactions [6].
To improve consumer safety, it is necessary to have rapid
and sensitive detection methods for food allergens that can
be routinely employed by food control authorities and food
processors. At present, enzyme-linked immunosorbent
assay (ELISA) is the most widely used method for allergen
detection [7–12]. However, ELISAs are relatively labor-
intensive and time-consuming, in particular for a small
number of samples. These drawbacks can be overcome by
the use of automated biosensors. The major advantages of
these systems are their short assay time, i.e., minutes, their
high degree of automation reducing labor time, the option
of simultaneous detection of several analytes (in most
machines), and the label-free detection. So far, only
Mohammed et al. [13] and Malmheden Yman et al. [14]
developed biosensor immunoassays (BIAs) intended for the
detection of allergenic products in the low microgram per
gram range. However, Mohammed et al. only measured
standard solutions and Malmheden Yman et al. had
extensive problems with nonspecific binding from food
extracts using polyclonal antibodies (PAbs). These matrix
problems could only partially be solved (i.e., for relatively
high allergenic product concentrations) by affinity purifi-
cation of the PAbs used and by applying a sandwich
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immunoassay format. Moreover, using polyclonal antibodies
means that there is a finite amount of antibodies. Also, the
use of a sandwich format doubles the analysis time.
In the present study, antihazelnut monoclonal antibodies
(MAbs), having in principle an infinite supply, were
developed and tested for specificity and sensitivity. We show
that using a very specific MAb and a biosensor equipped
with reference flow channels, in which the specific and the
nonspecific binding for each sample can be observed
simultaneously, a sensitive and specific direct BIA for
quantitative analysis of proteins from allergenic products at
trace levels in food can be developed. Furthermore, two
single-step BIA formats (direct and inhibition) were com-
pared. Hazelnut oils having different grades of refinement
and olive oils contaminated with crude hazelnut oil were
analyzed to evaluate this newly developed BIA.
Experimental
Instruments and reagents
1-Butanol, hydrochloric acid, phosphoric acid, sodium
carbonate, sodium chloride, sodium hydrogen carbonate,
and Tween 20 were purchased from VWR International
(Amsterdam, The Netherlands). Antifoam A, bovine serum
albumin (BSA), ovalbumin, and Tris(hydroxymethyl)
aminomethane (Tris) were supplied by Sigma-Aldrich
Chemie (Zwijndrecht, The Netherlands), liquid nitrogen
by Linde Gas Benelux B.V. (Rotterdam, The Netherlands),
and acetone by Biosolve (Valkenswaard, The Netherlands).
The bicinchoninic protein assay reagents were purchased
from Pierce (Rockford, IL, USA). Rabbit antimouse
immunoglobulins horseradish peroxidase (RAM-HRP)
was obtained from DAKO (Heverlee, Belgium), goat
antirabbit HRP (GAR-HRP) was from Sigma-Aldrich
Chemie (Zwijndrecht, The Netherlands), and goat anti-
mouse immunoglobulins alkaline phosphatase (GAM-AP)
from Southern Biotechnology (Birmingham, AL, USA). 5-
Bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium
(BCIP/NBT) phosphatase substrate and solutions of
tetramethylbenzidine (TMB) peroxidase substrate and per-
oxide were purchased from Kirkegaard and Perry Labs
(Gaithersburg, MD, USA). Marvel dried skimmed milk
powder was purchased from Premier International Foods
Ltd. (Spalding, UK) and the RIDASCREEN® Allergen
extraction buffer and RIDASCREEN® FAST Hazelnut
were from R-Biopharm AG (Darmstadt, Germany). Colloi-
dal gold total protein stain and Criterion Tris–HCl 10–20%
linear gradient gels were purchased from Bio-Rad Labora-
tories, Inc. (Veenendaal, The Netherlands). Acrodisc filters
were purchased from Pall Corporation (Ann Arbor, MI,
USA) and glass filter funnels from Fisher Emergo B.V.
(Landsmeer, The Netherlands). High-binding 96-well micro-
titer plates were purchased from Greiner Bio One (Alphen
a/d Rijn, The Netherlands) and the microplate reader
(Bio-tek Elx808 ultra) was from Bio-tek Instruments, Inc.
(Winooski, VT, USA). Protran nitrocellulose transfer
membrane of 0.2 μm was purchased from Schleicher &
Schuell Bioscience Inc. (Dassel, Germany). The Akta
purifier, HiTrap protein G columns (1 mL), the BIACORE
3000, sensor chips (CM5), HBS-EP buffer (pH 7.4,
consisting of 10 mM 4-(2-hydroxyethyl)piperazine-1-
ethanesulfonic acid, 150 mM sodium chloride, 3 mM
ethylenediaminetetraacetic acid, 0.005% v/v surfactant
polysorbate 20), and an amine coupling kit (containing
0.1 M N-hydroxysuccinimide (NHS), 0.4 M 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC),
and 1 M ethanolamine hydrochloride (pH 8.5)) were
purchased from GE Healthcare (Uppsala, Sweden).
Immunogens, hazelnut protein extracts, and extracts
for cross-reactivity studies
R-Biopharm AG kindly donated raw and roasted (140–
160 °C for over 30 min) hazelnut mixtures containing
different hazelnut varieties. For cross-reactivity studies,
extracts were derived from legumes and fruits (soybean;
chick pea; green pea; brown lentil; white bean; apple;
mango; apricot; raisin), nuts and stone fruits (pecan;
walnut; Brazil nut; hazelnut; coconut; almond; chestnut;
cashew; pistachio nut; peanut), and various ingredients
(dried egg white; egg yolk powder; cocoa butter; vanillin;
butter fat; cinnamon; cocoa; milk; yeast; pumpkin seed;
sunflower seed; sesame seed; poppy seed; wheat; rye; corn;
rolled oats; barley; rice) as well as thickening and gelling
agents (lecithin; carob; potato starch) and pollen (birch
pollen; hazel pollen; walnut pollen). The pollen were
obtained from Allergon AB (Ängelholm, Sweden); all
other products were obtained from the local market.
Extractions were performed as described elsewhere [10].
Monoclonal and polyclonal antibodies
Antihazelnut MAbs were developed according to a proce-
dure previously described for the production of anticasein
MAbs [15]. However, in this case, mice were immunized
with 50 μg extracted hazelnut protein (obtained from
roasted or mixtures of raw and roasted hazelnuts) and
booster injections contained 25 μg extracted hazelnut
protein. In total, 23 MAbs were obtained from four
immunized mice. Eight of the MAbs selected in this study
(see “Results and discussion” section) were isolated from
the raw cell culture media (about 1 L) by ammonium
sulfate precipitation followed by affinity chromatography
using a HiTrap Protein G column in accordance with the
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manufacturer’s instruction manual. Thirty milligrams of
purified MAb 50-5H9 (obtained from an immunization
with roasted hazelnuts), the MAb used in the BIA, were
obtained from 1 L of raw cell culture medium. Antihazelnut
PAbs were raised in rabbit and sheep according to a similar
immunization protocol as previously described for the
development of antiflumequine PAbs [16]. However, in
this case, extracted hazelnut proteins were used as the
immunogen.
Antipeanut MAbs were obtained according to the same
procedure as described above for the antihazelnut MAbs now
using peanut proteins as immunogen. One of these MAbs,
MAb 51–12D2 selected for its specificity toward peanut
proteins, was used in this study as a referenceMAb in the BIA.
Inhibition ELISA
All incubations were performed at a microplate shaker, for 1 h
at room temperature (RT), unless stated otherwise. High-
binding 96-well microtiter plates were coated with hazelnut
protein (100 μL per well of a 1 μg/mL solution) in coating
buffer (pH 9.6, 15 mM Na2CO3 and 35 mM NaHCO3).
Subsequently, the wells were emptied and blocked with
200 μL of an ovalbumin solution (0.1% (w/v) in coating
buffer). The plates were emptied, sealed, and could be stored
at −20 °C for at least 4 weeks. Prior to use and after every
step, as described in the following, the plate was washed
three times with washing buffer (phosphate-buffered saline
(PBS) containing 0.05% (v/v) Tween 20 and 0.004% (v/v)
antifoam A). Wells of the microtiter plate were filled with
50 μL of standard or sample extract diluted in PBS and
50 μL in PBS containing 0.05% (v/v) Tween 20 (PBST)
diluted MAbs or PAbs (e.g., in the final protocol, MAb 50-
5H9 (1.5 mg/mL) was applied in a 1:375,000 dilution). After
incubation and washing, the plate was incubated with
100 μL of GAR-HRP (in the case of rabbit PAbs) in a
1:5,000 dilution in PBST, RASH-HRP (in case of sheep
PAbs) in a 1:8,000 dilution in PBST, or RAM-HRP (in the
case of MAbs) in a 1:2,500 dilution in PBST. After washing
the plate, the bound peroxidase was assessed by adding
100 μL of a freshly prepared mixture (1:1 (v/v)) of TMB
peroxidase substrate and peroxidase. After incubation in the
dark for 30 min at RT, the reaction was stopped by adding
100 μL of 1 M phosphoric acid and the colored product was
measured at 450 nm using a microplate reader.
SDS-PAGE and immunoblotting
On an 18 comb Tris–HCl 10–20% linear gradient gel, 5 μg of
protein per lane were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and subse-
quently semi-dry-blotted onto a nitrocellulose membrane as
described elsewhere [17]. After blotting, the protein pattern
was visualized using a colloidal gold total protein staining in
accordance with the manufacturer’s manual. All the buffers
described in the following were based on a Tris buffer (TB;
pH 7.4, 50 mM TRIS, pH adjusted with 5 M HCl). The
binding pattern of MAb 50-5H9 was visualized by incuba-
tion of the blotted and blocked (1 h with TB containing 1%
w/v BSA) membrane with a dilution of MAb 50-5H9 in TB
containing 0.5% w/v Tween 20 for 1 h at RT. After three
washing steps with TB, the blot was incubated for 1 h at RT
with GAM-AP in a 1:1,000 dilution in TB containing 0.33%
w/v Marvel. After washing the blot, the bound alkaline
phosphatase was assessed by incubating with BCIP/NBT
phosphatase substrate until substantial color was obtained.
Washing with water stopped the reaction.
Biosensor chip preparation
In the direct BIA format, Prot-G-purified MAbs were immo-
bilized onto the biosensor chip (CM5) surface by the use of the
amine coupling kit and the Surface Preparation Wizard as
present in the BIACORE 3000 control software. The biosensor
surface was activated by injecting (35 μL at a flow rate of
5 μL/min) a mixture of EDC and NHS (1:1; v/v) into one of the
four flow channels (Fcs). Then the MAb, diluted (0.1 mg/mL)
in coupling buffer (10 mM sodium acetate, pH 4.5), was in-
jected and bound to the activated carboxymethylated dextran
surface via its primary amine groups. After coupling, the re-
maining active groups were blocked with ethanolamine (1 M).
Hazelnut oils and olive oils
Two hazelnut oils and six olive oils were bought at local
stores and two hazelnut oils and two olive oils were kindly
donated by Minerva S.A. Edible Oils Enterprises (Athens,
Greece). All oils were stored in the dark at room
temperature. Using a commercially available ELISA, it
was confirmed that the olive oils were blank.
Extraction procedure for oils
For extraction, 2.5 g of oil was rotated end over end with
2.5 mL of heated (60 °C) RIDASCREEN®Allergen extraction
buffer for 20 min at 60 °C. Prior to use in the BIA, the samples
were allowed to cool to room temperature. Upon cooling, a
phase separation occurred. Samples were taken from the lower
water phase. RIDASCREEN® Allergen extraction buffer is
included in Allergen ELISA test kits fromR-BiopharmAG and
is developed for extraction of matrices with high fat content.
Direct biosensor immunoassay
In the final format, the selected antipeanut MAb (MAb 51–
12D2) was immobilized in the reference Fc (Fc1) and the
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antihazelnut MAb 50-5H9 was immobilized in the mea-
surement Fc (Fc2). The BIACORE 3000 operated at a
temperature of 25 °C and the running buffer was HBS-EP.
During all analyses, 15 μL injections at a flow rate of
20 μL/min were applied and for regeneration 20 μL of a
10 mM NaOH solution was injected at a flow rate of 50 μL/
min. The total run time between two sample injections,
including washing and regeneration steps in the biosensor,
was 4.5 min. The relative responses measured 10 s before
the regeneration started were used for calculations. For
quantitative analysis, a calibration graph was prepared by
spiking extract of pure extra virgin olive oil with aqueous
hazelnut protein extracts [10] to give final hazelnut protein
concentrations of 0–5 μg/mL. Extracts of pure hazelnut oils
were diluted in extract of pure extra virgin olive oil when
needed. All samples and spiked samples were analyzed in
duplicate.
Results and discussion
Specificity and sensitivity of the antisera
Antihazelnut antibodies were tested in the inhibition ELISA
for sensitivity with standard solutions of hazelnut protein (0
to 1,000 μg/mL) and for specificity with over 40 different
foods and ingredients. The extracts of these foods and
ingredients contained between 0.04 and 22 mg/mL of
protein. Extracts with high protein content were tested at a
protein concentration of 1 mg/mL. Extracts with protein
content lower than 1 mg/mL were tested at the highest
concentration possible. Practically all PAbs cross-reacted
with various foods and/or ingredients. This was also
observed by Holzhauser and Vieths [7] and by Malmheden
Yman et al. [14], whose PAbs all displayed cross-reactivity
with various food extracts even after affinity purification. A
major part of the developed antihazelnut MAbs also
displayed strong cross-reactions, in particular, with tree
nuts. Eight out of the 23 obtained MAbs showed high
specificity (no detectable cross-reactivity with any of the 40
extracts) and sensitivity (50% inhibition around 5 μg/mL)
for hazelnut proteins. The antipeanut MAb applied in the
reference Fc of the biosensor was selected in the inhibition
ELISA (using peanut-protein-coated microplates) because
of its specificity towards peanut proteins.
SDS-PAGE and immunoblotting of raw and roasted
hazelnuts
In food and oil production, raw and roasted hazelnuts are
both used. To evaluate whether the protein binding profile
of the MAbs was affected by roasting, a comparison was
made between extracts from raw and roasted hazelnuts. The
amount of extracted protein was about 10% higher for raw
than for roasted hazelnuts. Holzhauser and Vieths [7] also
observed that the amount of extractable protein from
hazelnut and peanut varied, depending on the type of nut
and the roasting conditions. This means that, depending on
the nut extract used for calibration, there might be a (small)
deviation between measured and exact amount of hazelnut
protein present in food. Extracts of a raw and roasted
mixture of different hazelnut varieties were characterized
by SDS-PAGE followed by Western blotting and immuno-
blotting (Fig. 1). The protein profiles (Fig. 1, lanes A1 and
A2) are in good agreement with hazelnut protein profiles
described in literature [7, 9] and are almost identical for raw
and roasted extracts. All 23 MAbs were tested in
immunoblotting and the results for MAb 50-5H9 are shown
in Fig. 1 (lanes B1 and B2). MAb 50-5H9 recognized
proteins between 20 and 65 kDa and no difference in
binding profile to raw and roasted extracts was observed.
Out of all MAbs, MAb 50-5H9 was selected for application
in the BIA as it demonstrated good sensitivity (50%
inhibition around 5 μg/mL) and good specificity (no
detectable cross-reactivity with the 40 tested foods and
food ingredient extracts); it was obtained from a productive
cell line and its detection of hazelnut proteins was not
influenced by the roasting process. Thus, MAb 50-5H9 can
be applied in immunoassays to detect traces of hazelnut in a
range of processed food products with minimal risk of
false-positive or false-negative test results.
Fig. 1 Colloidal gold-stained Western blot (lanes M, A1, and A2) and
MAb 50-5H9 incubated immunoblot (lanes B1 and B2) of raw (1) and
roasted (2) hazelnut extracts (M = molecular mass marker)
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Inhibition biosensor assay
In the biosensor, immunoassays can be developed in an
inhibition and direct format (with extension to a sandwich
format). In general, the inhibition format, with the antigen
coated on the chip, is the more robust and stable assay
format [15, 18]. On the other hand, the direct assay format,
with the antibodies coated, has the advantages of a single
reagent format, the use of only small amounts of antibodies,
and a wide measurement range [15]. In this study, both
assay formats were compared. For the inhibition assay, a
hazelnut protein extract was coated to the chip and a high
final immobilization response was observed (approximately
4,500 RU). The reference Fc was only activated with EDC/
NHS and deactivated with ethanol amine; no reference
protein was coated. MAb 50-5H9 was injected over the
coated surface but only a very low response (approximately
60 RU) was observed. However, after injection of a PAb, a
high response (approximately 2,500 RU) was observed in
the hazelnut-coated Fc and a low response in the reference
Fc, indicating specific binding of the PAb to the coated
hazelnut proteins. This difference in binding of both
antibodies to the coated hazelnut proteins must be a result
of the higher specificity of MAb 50-5H9. This MAb only
binds to a few specific proteins in the hazelnut extract (see
Fig. 1, lanes B1 and B2) whereas PAbs can bind to a whole
range of proteins. As a total protein extract is used for chip
coating, the relative amount of the MAb-specific proteins
on the chip is small, leading to low responses, whereas the
amount of protein to which the PAbs can bind is much
higher, leading to high responses. This problem might be
overcome by affinity isolation of specific hazelnut proteins
by MAb 50-5H9 and subsequent coating of these purified
proteins on the chip. However, this is a labor-intensive
protocol that requires high amounts of antibody. This
renders the inhibition format less suitable for this specific
application.
Direct biosensor assay
A direct BIA was developed to detect hazelnut proteins in
hazelnut and olive oils. For this, prot-G-purified MAb 50-
5H9 was immobilized onto the biosensor chip surface into
Fc 2. A final response of 12,500 RU was obtained
corresponding to 15 ng protein. In the reference Fc (Fc 1),
the antipeanut MAb was immobilized to serve as blank and
a final response similar to that obtained in Fc 2 was
obtained. To assess the suitability of the BIA, extracts of
pure extra virgin olive oil spiked with hazelnut proteins
were injected through the two serially connected Fcs. For Fc
2 (the antihazelnut-coated Fc), this resulted in sensorgrams
as shown in Fig. 2. The sharp change in signal upon
switching between the olive oil extract and the HBS-EP
buffer are caused by the difference in refractive index of
both solutions. During sample injection, the signal in the
antihazelnut channel increased steadily with time as a
result of the binding of hazelnut proteins. Low responses
(approximately 4 RU) were observed for all solutions in
the antipeanut-coated reference Fc, which indicates the
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Fig. 2 Sensorgrams obtained
with the direct BIA in the
antihazelnut-coated flow
channel after injecting olive oil
extracts spiked with different
hazelnut protein concentrations
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Fig. 3 Calibration curve of hazelnut proteins in an extract of pure
olive oil as obtained with the direct BIA. Samples were measured in
duplicate and standard deviations are shown as error bars
Biosensor immunoassay 123
absence of nonspecific binding. This is in strong contrast
to the findings of Malmheden Yman et al. [14], who had
extensive problems with nonspecific binding from food
extracts. These matrix problems were only partially solved
by affinity purification of the PAbs used and by applying a
sandwich immunoassay format. The use of a sandwich
immunoassay format, however, doubled the analysis time
and in the low concentration range nonspecific surface
binding was still observed. The low nonspecific binding
observed in our case may be the result of the use of a very
specific MAb and of low concentrations of interfering
components in oil. Moreover, the use of a biosensor
equipped with a reference Fc would have allowed for
subtraction of nonspecific binding when encountered. The
hazelnut proteins were strongly bound by the antihazelnut
MAb, as rinsing with HBS-EP buffer (after the end of the
injection) did not cause any dissociation. To completely
remove the bound hazelnut proteins, i.e., regeneration,
20 μL of a 10 mM NAOH solution was injected. The time
needed for one complete analysis is about 4.5 min, whereas
the analysis time of an (commercial) ELISA is much
longer, approximately 1 or 3 h for fast or classical ELISAs,
respectively. Although more samples can be analyzed in
parallel using ELISAs, approximately 15 samples for fast
ELISAs and 40 for classical ELISAs, the same analysis
time is required for smaller number of samples. Hence, the
developed BIA is very suitable for online detection and it pro-
duces results the fastest for approximately 15 samples or less.
Calibration curve and limit of detection
A calibration curve was constructed by plotting the
concentrations of hazelnut protein (0–5 μg/mL) in extracts
of pure extra virgin olive oil against the responses in the
biosensor (Fig. 3). The response in the antihazelnut-coated
Fc increased linearly with hazelnut protein concentration up
to a concentration of 2.5 μg/mL. At a concentration of
5 μg/mL, the signal slightly leveled off. For reasons of
accuracy, we used the linear calibration curve between 0
and 2.5 μg/mL. The limit of detection (LOD) of the assay
was determined by analyzing eight different blank olive oils
obtained from local markets in The Netherlands and
Greece. Due to the applied extraction procedure (2.5 g of
oil with 2.5 mL of extraction buffer), the concentrations of
hazelnut proteins in the oil (μg/g) are similar to the
concentrations in the extraction buffer (μg/mL). An LOD,
defined as the concentration corresponding to the average
signal from blank samples plus three standard deviations, of
0.08 μg/g was determined. This LOD is in the same range
as commercially available ELISA kits and as the biosensor
assay described previously [14]. To increase food safety for
hazelnut-allergic individuals, analytical methods should be
able to detect at least 1–2 μg/g of hazelnut protein in a food-
stuff. In this way, only mild or no allergic reactions are to be
expected [7]. Obviously, our BIA meets this requirement.
Fig. 4 Colloidal gold-stained
Western blot of crude hazelnut
oil extract (M = molecular mass
marker, Oil = hazelnut oil
extract)
Prepared mixture of hazelnut
oil in olive oil (%)
Hazelnut protein concentration (μg/g) Recovery (%)
Found in mixture Calculated to pure hazelnut oil
0.00625 0.10 1,559 93
0.0125 0.20 1,604 96
0.025 0.41 1,636 98
0.05 0.80 1,605 96
0.25 4.2 1,689 101
0.5 9.1 1,825 109
1 16.3 1,625 97
5 87.4 1,748 105
30 530 1,744 104
100 1,673 1,674 100
Table 1 Concentrations of
hazelnut proteins found with the
BIA in prepared mixtures of
hazelnut oil and olive oil.
Hazelnut protein concentrations
in pure hazelnut oil and
recoveries were calculated
from the concentrations in the
mixtures (correcting for the
dilution)
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Analysis of hazelnut oils
Four hazelnut oils were extracted and tested in the BIA. In
one of the Greek virgin hazelnut oils, a high concentration
of approximately 1,670 μg/g of hazelnut proteins was
measured (after analyzing in and correcting for high diluted
extracts). In the other Greek hazelnut oil, a concentration of
only 0.35 μg/g hazelnut proteins was detected. In both
hazelnut oils from the Dutch local market, the concentration
of hazelnut proteins was below the LOD of 0.08 μg/g. A
hazelnut oil analyzed by Teuber et al. [5], which was a
blend of refined and unrefined oil in unknown proportion,
contained 62 μg/mL of hazelnut protein. It is clear that the
protein content of hazelnut oils depends on the refinement
grade and that it can vary significantly. Similar observations
were made for other vegetable and nut oils [5, 19–21]. In
general, crude oils may contain up to a few hundred
micrograms of protein per milliliter whereas highly refined
oils may have a 100-fold lower protein content [6]. From
the protein content, it is obvious that one Greek hazelnut oil
was a crude oil and that the low-priced ones from the local
market were highly refined. An important observation is
that proteins present in oils can still be allergenic [5, 6].
Therefore, olive oils adulterated with crude hazelnut oils,
even at a low percentages, may contain enough protein to
pose a threat to allergenic individuals. A protein profile of
the crude hazelnut oil extract is shown in Fig. 4. This
protein profile and the profile of the hazelnut extract used
for calibration are similar (Fig. 1). The protein bands from
the hazelnut oil extract are less intense and some bands
seem to be missing due the low protein concentration in the
extract. However, all proteins detected by MAb 50-5H9
(Fig. 1) are present in the oil extract. This demonstrates that
the extract used for calibration is representative for extracts
obtained from (crude) hazelnut oil and can be used for
calibration.
Analysis of olive oil adulterated with hazelnut oil
To assess the suitability of the assay for the detection of
hazelnut proteins in olive oil, we mixed pure olive oil with
different amounts (from 0.00625% up to 100%) of the
crude Greek hazelnut oil that contained a high concentra-
tion of hazelnut proteins. By mixing these two oils, a more
homogenous distribution of hazelnut proteins in the olive
oil is obtained than by mixing olive oil with an aqueous
solution of hazelnut proteins. The hazelnut protein concen-
trations were determined and results are presented in Table 1
which shows that even a low concentration as 0.00625%
hazelnut oil, i.e., 0.10 μg/g hazelnut protein, can be
detected. From the protein concentrations in these mixtures,
the concentrations of hazelnut protein in pure hazelnut oil
were calculated by multiplying for the applied dilutions in
olive oil. Recoveries, calculated as percentages of the
protein concentration found in the pure hazelnut oil, varied
between 93% and 109% and, even at very low concen-
trations, there was a good recovery. The standard deviation
of the recovery over all samples was about 5%.
In literature, the protein content of only one partially
unrefined hazelnut oil could be found [5]. This blend of
refined and unrefined hazelnut oil contained 62 μg/mL of
hazelnut protein which correlates to 68 μg/g (using a
density of 0.91 g/cm3 at 20 °C, http://www.oilsbynature.
com). The developed BIA should be able to detect hazelnut
proteins in olive oils adulterated with only 0.12% of this
hazelnut oil. From these results, it can be concluded that the
developed BIA can indeed be used for the detection of
hazelnut protein from (unrefined) hazelnut oil in olive oils
at very low adulteration levels.
Conclusions
In conclusion, in this study, it is demonstrated that a
biosensor immunoassay, based on a highly specific mono-
clonal antibody and developed in a biosensor equipped with
a reference channel, can be used for specific and quantita-
tive analysis of proteins from allergenic products at trace
levels. With the developed assay, a concentration as low as
0.08 μg/g of hazelnut proteins can be detected in olive oils,
rendering this assay sufficiently sensitive to detect hazelnut
protein at levels where only mild or no allergic reactions are
to be expected. With a limit of detection that is comparable
to or even lower than the most sensitive ELISAs, it is
obvious that the biosensor immunoassay, which is much
faster and less labor consuming and due to its high degree
of automation suitable for online analysis, can play an
important role in increasing food safety.
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